FDA Approves Emergency Use of CDC Test for Zika Virus

Share this content:
FDA Approves Emergency Use of CDC Test for Zika Virus
FDA Approves Emergency Use of CDC Test for Zika Virus

MONDAY, Feb. 29, 2016 (HealthDay News) -- The U.S. Food and Drug Administration has issued an Emergency Use Authorization (EUA) for a diagnostic tool for Zika virus that will be distributed to qualified laboratories, according to a media statement issued by the U.S. Centers for Disease Control and Prevention.

The test is called the CDC Zika immunoglobulin M (IgM) Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA), and is intended for use on blood samples from people with a history of symptoms associated with Zika and/or people who have recently traveled to an affected area. The IgM antibodies in response to infection appear in the blood beginning four to five days after the start of illness and last for about 12 weeks.

When positive or inconclusive results occur, additional testing with a plaque reduction neutralization test is recommended to confirm the presence of antibodies to Zika virus. This additional testing will be performed by the CDC or a CDC-authorized laboratory.

"The CDC will begin distributing the test during the next two weeks to qualified laboratories in the Laboratory Response Network, an integrated network of domestic and international laboratories that can respond to public health emergencies," according to the media statement. "The test will not be available in U.S. hospitals or other primary care settings."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »